SCHEMBL4433518

SCHEMBL4433518

CCOC(=O)C(Cc1ccc(Cl)c(OC(F)(F)F)c1)C(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.43
PPARG P37231 3/20 0.39
KDM4A O75164 2/20 0.39
KDM5A P29375 2/20 0.39
EPHX2 P34913 2/20 0.39
APP P05067 2/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
PPARA Q07869 2/20 0.38
LDHA P00338 1/20 0.37
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
MMP8 P22894 1/20 0.37
FFAR1 O14842 1/20 0.37
FBP1 P09467 1/20 0.36
PPARD Q03181 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4439036 0.87 EPHX2 (0.40) PPARGEPHX2APPPPARALDHA
SCHEMBL2424748 0.83 IDO1 (0.45) PPARGEPHX2CYP3A4CYP2C9PPARA
SCHEMBL5108184 0.83 EPHX1 (0.47) EPHX1PPARGKDM4AKDM5APPARA
SCHEMBL2423843 0.82 SMN1; SMN2 (0.54) CYP3A4CYP2C9TSHRSMN1; SMN2CYP4F2
SCHEMBL4443597 0.82 LDHA (0.51) EPHX1PPARGKDM4AKDM5AEPHX2
SCHEMBL4725139 0.78 CYP4F2 (0.46) EPHX2LDHACYP4F2CYP4A11
SCHEMBL4564004 0.78 MAPK1 (0.52) EPHX1PPARGEPHX2CYP2C9PPARA
SCHEMBL3773692 0.78 LDHA (0.50) LDHATSHRSMN1; SMN2ALDH1A1
SCHEMBL5753792 0.76 MDM2 (0.40) PPARGEPHX2ALDH1A1
SCHEMBL16322462 0.76 EPHX1 (0.47) EPHX1PPARGKDM4AKDM5APPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137187-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE Inovacia AB (SE) 2009-12-30 EP disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 EPHX1 1600/4885PPARG 203/4885KDM4A 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.